Can Lykos Therapeutics Address MDMA-AT Safety Concerns Ahead of FDA Decision? - Lucid News
As Lykos Therapeutics considers a Risk Evaluation and Mitigation Strategy for MDMA-assisted therapy, both supporters and detractors of MDMA-AT make their case for whether the treatment is safe for patients.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
